Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Oct 16, 2020 Theratechnologies Appoints Two New Board Members Oct 15, 2020 Theratechnologies Announces Financial Results For The Third Quarter Of Fiscal 2020 Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH Oct 05, 2020 Theratechnologies To Announce Financial Results For Third Quarter 2020 Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5 Sep 21, 2020 Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results Sep 10, 2020 Theratechnologies Announces Launch Of Trogarzo® In Germany Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020 Jul 23, 2020 Theratechnologies Reports That Tesamorelin Improves Liver Health First page « Previous page ‹ … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page › Last page » Displaying 161 - 170 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH
Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5
Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population
Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020
